The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the challenge with making glp1 into a drug is that it has an extremely short halflife so it has a half life about 2 minutes in the blood — and so even if you inject people with glp1 it won't really be useful for anything you don't decrease appetite you don't affect blood sugar because just degraded too fast
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.